Dan Shelly

Company: PolTREG

Job title: Chief Business Development Officer

Seminars:

Measuring T-Regulatory Cells: Working Towards a Gold Standard for Assessing Immune Tolerance with Enhanced Accuracy 2:00 pm

• Reviewing the strengths and limitations of existing approaches for quantifying CD4+ cells in the blood • Discussing the potential for T-cells as valuable clinical biomarkers for monitoring immune tolerance and treatment response • Exploring how T-cells can be used to assess immune reprogramming rather than suppressionRead more

day: Conference Day One